The second edition of our survey, expanded with contributions from 28 member organisations across 21 European countries with thanks to the Research Subcommittee group of ADHD led by Stephanie Clark.
Members updated survey responses from 2009, which covered issues related to diagnosis and treatment, including the availability and cost of medications, reimbursement of medication and other treatment costs, the education of professionals concerned with ADHD, employment of people with ADHD and national policy. In 2011 additional questions covered recognition and treatment of the inattentive subtype ADHD-I and coaching for people with ADHD. The information in this booklet is based on responses from all twenty-one member countries, unless otherwise indicated. In countries with more than one member organisation, national organisations either cooperated on their survey response or separate survey responses were compiled by the researcher for each country.